U.S. patents available from 1976 to present.
U.S. patent applications available from 2005 to present.

Icon_funbox Quotables

"What can be more palpably absurd than the prospect held out of locomotives traveling twice as fast as stagecoaches?"

The Quarterly Review ; March edition, 1825

Newsletter  PatentStorm News

Make the Most of Our Site

See this month's Top Inventors and Most Cited Patents.

Stay on top of the latest innovations by subscribing to an RSS feed.

Registered users: Manage your profile.

 

Inventor: Paolo Morazzoni


Address: Milano, IT
No. of applications: 20
Last application issue date: 05/19/2011

Application No.Application TitleIssue Date
20110118182PROCESS FOR THE EXTRACTION, PURIFICATION AND ENZYMATIC MODIFICATION OF SOY 7S GLOBULIN ALPHA' SUBUNIT FOR USE AS HYPOCHOLESTEROLEMIZING AGENT
A purified amino-terminal polypeptide fragment of the soy β-conglycinin α′ subunit is prepared by selective extraction of defatted soy with an aqueous solution of sodium bisulfite, precipitation with ethanol, and Metal Affinity Chromatography (MAC) under denaturing ...
05/19/2011
20110104313COMPOSITIONS FOR THE TREATMENT OF VAGINAL INFECTIONS WITH CHRONIC INFLAMMATION
The present invention relates to compositions comprising benzofuran compounds and benzophenanthridine alkaloids, which possess anti-inflammatory, antibacterial and antifungal activity useful in the treatment of vaginal infections and the resulting inflammatory states....
05/05/2011
20110091392COMPOSITIONS FOR THE TREATMENT AND PREVENTION OF INFECTIONS OF THE ORAL CAVITY
The present invention relates to compositions comprising benzophenanthridine alkaloids, benzofuran compounds and catechin polyphenols, which are useful in the treatment and prevention of infections of the oral cavity....
04/21/2011
20110014306FORMULATIONS WITH SANGUINARINE, CHELERYTHRINE OR CHELIDONINE FOR THE TREATMENT OF WARTS, VERRUCAS AND PSORIATIC PLAQUES
The invention provides formulations containing sanguinarine, chelerythrine or chelidonine or their salts or extracts containing them, mixed with suitable vehicles and/or excipients, for the treatment of common skin warts and verrucas, anal and vulvar warts and psoriatic...
01/20/2011
20100331525ANTITUMORAL AGENTS WITH A BENZOPHENANTHRIDINE STRUCTURE AND FORMULATIONS CONTAINING THEM
The use of benzophenanthridine alkaloids and the salts thereof for the preparation of medicaments for the treatment of tumors is disclosed....
12/30/2010
20100310684METHODS FOR TREATING AND PREVENTING MUCOSITIS
Methods for treating and preventing mucositis, in particular mucositis following the administration of chemotherapy drugs or a combination of said drugs with radiotherapy, are disclosed herein. More specifically, disclosed herein is the administration of a therapeutical...
12/09/2010
20100047339COMPOSITIONS FOR THE TREATMENT OF CHRONIC DEGENERATIVE INFLAMMATORY CONDITIONS
Compositions comprising:
    • saligenin or derivatives thereof or Salix ssp extracts containing from 10 to 50% of sal...
02/25/2010
20090285911Cynara scolymus extracts, the use thereof and formulations containing them
The present invention relates to the preparation of a Cynara scolymus extract obtainable by fractioning on a resin. The process of the invention allows to obtain an extract, starting from the aerial parts of the plant Cynara scolymus, containing three clas...
11/19/2009
20080226757Use of a Ginkgo Complexes for the Enhancement of Cognitive Functions and the Alleviation of Mental Fatigue
The invention is directed to the use of Ginkgo complexed with phosphatidylserine for the manufacture of a medicament or a dietary supplement for the enhancement of cognitive function and mental fatigue, i.e. to improve the factors related therewith such as to improve th...
09/18/2008
20080220096CYNARA SCOLYMUS EXTRACTS AND COMPOSITIONS CONTAINING THEM
The present invention relates to a Cynara scolymus extract with a high caffeoylquinic acid content, obtainable by extraction from undried globe artichoke heads with alcohols having up to three carbon atoms....
09/11/2008
20080220097FORMULATIONS CONTAINING CYNARA SCOLYMUS AND PHASEOLUS VULGARIS EXTRACTS WHICH ARE USEFUL IN THE TREATMENT OF OBESITY
The present invention relates to a Cynara scolymus extract with a high content of caffeoylquinic acids, and a composition containing said Cynara scolymus extract with a Phaseolus vulgaris extract.

Said composition is us...

09/11/2008
20080220098FORMULATIONS OF ALPHA-AMYLASE INHIBITORS WITH ALPHA-GLUCOSIDASE INNHIBITORS USEFUL IN THE TREATMENT OF DIABETES AND OBESITY
This invention relates to the combination of α-amylase inhibitors prepared from Phaseolus vulgaris with α-glucosidase inhibitors obtained from Salacia oblonga and other species. The α-amylase inhibitor is accompanied by a quantity of lectins that reduce...
09/11/2008
20080132573Trpv1 Agonists, Formulations Containing Them and Uses Thereof
The compounds of the general formula (I) in which X is represents two hydrogen atoms, a π-bond, oxygen or methylene: R2 is a C6-C12 aryl, or arylalkyl residue: R3 is hydrogen, 2-hydroxyethyl or 2-aminoethyl are useful for the treatment of patholog...
06/05/2008
20080026058METHODS FOR TREATING AND PREVENTING MUCOSITIS
Methods for treating and preventing mucositis, in particular mucositis following the administration of chemotherapy drugs or a combination of said drugs with radiotherapy, are disclosed herein. More specifically, disclosed herein is the administration of a therapeutical...
01/31/2008
20060142185Use of lupin conglutin for the treatment of type II diabetes
A method for the use of lupin conglutin gamma or of proteins showing homology higher than 50% with lupin conglutin gamma, for the preparation of a medicament, food supplements or foods for the treatment of type II diabetes, pharmaceutical and nutritional compositions co...
06/29/2006
20050220905Formulations useful in the treatment of male and female impotence
Disclosed are pharmaceutical compositions containing: extracts of Tribulus terrestris, Turnera diffusa and Cinnamon cassia in tile weight ratio of 1.5-3.5:1-2:0.1-0.4 respectively; Ginkgo biloba extract, and optionally arginine or a physiologically ...
10/06/2005
20050222274Hyperforin halogenated derivatives, the use thereof and formulations containing them
Hyperforin and adhyperforin halogenated derivatives of general formula (I) in which X, R and R1 have the meanings as defined in the disclosure, the process for the preparation thereof and the use thereof in the pharmaceutical and/or nutritional field, in part...
10/06/2005
20050175722Formulations useful in the reatment of male and female impotence
Pharmaceutical compositions containing: extracts of Tribulus terrestris, Epimedium koreanum, Cinnamon cassia in the weight ratio of 1.5-3.5:1-2:0.1-0.4 respectively; and optionally arginine or a physiologically equivalent ester, salt or precursor thereof. The com...
08/11/2005
20050164337Process for the extraction, purification and enzymatic modification of soy 7s globulin alpha' subunit for use as hypocholesterolemizing agent
A process for the extraction, purification and enzymatic modification of β-conglycinin α′ subunit, wherein β-conglycinin is selectively extracted from ground, defatted soy, then precipitated by treatment with aqueous ethanol; the enriched fraction is then subjected...
07/28/2005
20050165117Hyperforin derivatives, the use thereof and formulations containing them
The use of the reduction products of hyperforin and adhyperforin, pharmanceutically acceptable salts or esters thereof, in the pharmaceutical and/or nutritional field, ii particular in the treatment of depression and Alzheimer's disease. ...
07/28/2005
 
Sign InRegister
Username  
Password   
forgot password?